Hydroxyurea Management During Infection
Risks and Considerations
- Hydroxyurea causes bone marrow suppression affecting all cell lines, including white blood cells needed to fight infection, according to Praxis Medical Insights 1
- For patients with polycythemia vera or essential thrombocythemia, infection during hydroxyurea treatment may exacerbate cytopenia, particularly if platelet counts fall below a certain threshold, as noted by the National Comprehensive Cancer Network 1, 2
- Hydroxyurea may increase the risk of pancreatitis, hepatic events, and peripheral neuropathy in patients with HIV, as reported by the American College of Physicians 4
Disease-Specific Guidance
- In sickle cell disease, hydroxyurea plays a critical role in reducing complications, but temporary dose adjustment may be needed during infection, according to the American Thoracic Society 3
- The benefits of continuing hydroxyurea in sickle cell disease patients with stable infections may outweigh risks in some cases, as it reduces vaso-occlusive crises, as noted by the American Thoracic Society 3
Management and Monitoring
- Consider dose reduction rather than complete discontinuation for patients with chronic conditions requiring continuous hydroxyurea therapy, based on blood count monitoring, as recommended by Praxis Medical Insights 1
- Monitor for potential drug interactions between hydroxyurea and antimicrobial agents, as advised by the American Academy of Dermatology 5